Freeman Roy Lester 4
4 · Inhibikase Therapeutics, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Freeman Roy Lester
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-14+22,640→ 22,640 totalExercise: $2.35Exp: 2035-02-14→ Common Stock (22,640 underlying)
Footnotes (1)
- [F1]The options vested and became exercisable on February 14, 2025.